A cannabinoid research headline may describe a finding as “significant,” while the results table shows an estimate followed by a confidence interval. Those details answer different questions. The estimate describes the observed difference; the interval helps readers judge its precision. Neither, by itself, tells us whether a finding matters in practice.
This guide explains how to read those numbers without turning a statistical label into a claim about a cannabinoid, a product, or an individual outcome.
What does a 95% confidence interval mean?
A study measures a sample rather than an entire population. Its point estimate is one numerical summary, while a confidence interval expresses sampling uncertainty around that estimate.
The “95%” describes the long-run performance of the calculation: if comparable studies were repeated and an interval calculated each time using the same valid method, approximately 95% of those intervals would contain the true population value. It is not a statement that 95% of participants experienced a result, or that an individual has a 95% chance of a particular outcome.
The National Library of Medicine’s confidence-interval tutorial explains this repeated-sampling interpretation. Read the interval alongside the measurement units and the comparison being made.
Find the no-difference value first
For a difference between group averages, the no-difference value is zero. For a risk ratio or odds ratio, it is one. These measures are not interchangeable; our guide to absolute risk, relative risk and odds in cannabinoid headlines explains the distinction.
If a conventional two-sided 95% interval includes the relevant no-difference value, its matching test generally does not meet the familiar 0.05 significance threshold. Check that the interval and test use corresponding methods. An interval crossing that value should prompt a closer reading of its full range, rather than an automatic verdict of “nothing happened.”
A fictional example: same estimate, different uncertainty
The following numbers are invented for explanation. They are not findings from a cannabinoid study. Imagine two groups compared on an unspecified research score, with positive differences meaning higher scores in the first group.
- Report A: difference of 2 points, 95% confidence interval from −1 to 5.
- Report B: difference of 2 points, 95% confidence interval from 1.5 to 2.5.
Both reports have the same central estimate. Report A leaves a much wider range unresolved, including zero and differences in either direction. Report B is more precise and excludes zero. Yet without knowing what the score measures, neither report tells readers whether two points is important.
Now suppose, purely within this fictional exercise, that a well-justified important-difference threshold had been set at 4 points. Report A does not resolve whether that threshold is reached. Report B places its entire interval below it. This extra reference point changes the interpretation without changing either estimate.
Statistical significance is not clinical importance
The CDC’s definition of statistical significance emphasizes that sample size affects what differences can be detected. Large samples can detect small differences; small samples can leave potentially meaningful differences statistically unresolved.
Consequently, comparing papers only by their significant or nonsignificant labels can be misleading. Ask for the effect size, units, interval and sample size together. A threshold label compresses information that readers need to evaluate the result.
NCCIH’s guide to reading scientific results distinguishes statistical significance from clinical significance: a measurable group difference may be too small to be useful to patients. The guide also encourages comparison with earlier studies and attention to financial or reputational interests. A single paper rarely settles a question.
Check what the statistical label leaves out
Before summarizing a paper, write down the comparison, outcome, measurement scale and follow-up period. Then record the estimate and both interval limits, rather than copying only a significance label. When two reports appear to disagree, compare those details before treating the headlines as contradictory. A change in sample size or precision can change a threshold label without producing a substantially different estimate.
A narrow interval is not a guarantee against bias
Precision is only one part of credibility. A narrow interval does not remove systematic problems in study design, reporting or relevance. Cochrane’s guidance on interpreting results separates imprecision from concerns such as bias, inconsistency and indirectness.
Likewise, failure to establish a difference is not automatically evidence of no meaningful effect. A wide interval may leave important differences unresolved. A sufficiently precise interval excluding differences judged important can support a more informative conclusion, subject to study quality and context.
When reading cannabinoid research, keep three questions separate: What difference was estimated? How uncertain is it? How trustworthy and relevant is the evidence? Our introduction to systematic reviews and certainty in cannabinoid research develops that final question. Read the numbers before accepting the headline.